BioNTech to invest $43 mln in German facility for mRNA vaccine building block https://ift.tt/2H98ixp

BioNTech and partner Pfizer - as well as rival Moderna - at the time scrambled to build a heavy-duty messenger RNA manufacturing network with dozens of external partners from scratch to produce COVID vaccines, in a technology that previously had no commercial application.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/qJA3O4z
Share:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Labels

Blog Archive

Recent Posts

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.